Head of Business Development
Paul brings more than 15 years of business development leadership and transactional experience within biotech and MNCs on both buy and sell sides across multiple therapeutic areas. Prior to joining SciNeuro, he served in senior business development roles at Adaptimmune Therapeutics, Inovio Pharmaceuticals and Nimbus Therapeutics, where he successfully led and closed multiple major and strategic clinical and preclinical stage asset and platform technology transactions. Previously, he was a Senior Director, Worldwide Business Development at GlaxoSmithKline. Paul is a scientist by background earning a BSc, then PhD in Pharmaceutical Sciences from the Universities of Bath and Nottingham, respectively. He also holds an MBA from Lehigh University, Bethlehem, PA.